These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17679021)

  • 1. Coagulation factor concentrates: past, present, and future.
    Key NS; Negrier C
    Lancet; 2007 Aug; 370(9585):439-48. PubMed ID: 17679021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant clotting factors.
    Pipe SW
    Thromb Haemost; 2008 May; 99(5):840-50. PubMed ID: 18449413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement products.
    Millar CM; Makris M
    Br J Haematol; 2012 Aug; 158(4):442-52. PubMed ID: 22775486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the treatment of inherited coagulation disorders.
    Escobar MA
    Haemophilia; 2013 Sep; 19(5):648-59. PubMed ID: 23600951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-generation recombinant factor concentrates: bridge to gene therapy.
    Ragni MV
    Haemophilia; 2001 Jan; 7 Suppl 1():28-35. PubMed ID: 11240616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint WFH-ISTH session: issues in clinical trial design.
    Peyvandi F; Farrugia A; Iorio A; Key NS; Srivastava A
    Haemophilia; 2014 May; 20 Suppl 4():137-44. PubMed ID: 24762289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel products for haemostasis - current status.
    Oldenburg J; Albert T
    Haemophilia; 2014 May; 20 Suppl 4():23-8. PubMed ID: 24762271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of plasma-derived clotting factor concentrates.
    Hoots WK
    Haemophilia; 2001 Jan; 7 Suppl 1():4-9. PubMed ID: 11240612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of coagulation factor concentrates.
    Teitel JM
    Haemophilia; 1998 Jul; 4(4):393-401. PubMed ID: 9873760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modern haemophilia care.
    Berntorp E; Shapiro AD
    Lancet; 2012 Apr; 379(9824):1447-56. PubMed ID: 22456059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The improved factor concentrate.
    Lillicrap D
    Hamostaseologie; 2009 Jan; 29(1):71-3. PubMed ID: 19151851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma-derived biological medicines used to promote haemostasis.
    Ofosu FA; Freedman J; Semple JW
    Thromb Haemost; 2008 May; 99(5):851-62. PubMed ID: 18449414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focus on factors.
    McDaniel P
    J Intraven Nurs; 2000; 23(5):282-9. PubMed ID: 11847739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety Issues of Plasma-Derived Products for Treatment of Inherited Bleeding Disorders.
    Farrugia A
    Semin Thromb Hemost; 2016 Jul; 42(5):583-8. PubMed ID: 27077709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in clotting factor treatment for congenital hemorrhagic disorders.
    Tarantino MD; Aledort LM
    Clin Adv Hematol Oncol; 2004 Jun; 2(6):363-8. PubMed ID: 16163206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Therapy for Coagulation Disorders.
    Swystun LL; Lillicrap D
    Circ Res; 2016 Apr; 118(9):1443-52. PubMed ID: 27126652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Evolution of the Safety of Plasma Products from Pathogen Transmission-A Continuing Narrative.
    Farrugia A
    Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology.
    Keeling D; Tait C; Makris M
    Haemophilia; 2008 Jul; 14(4):671-84. PubMed ID: 18422612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New high-technology products for the treatment of haemophilia.
    Pipe SW; Saint-Remy JM; Walsh CE
    Haemophilia; 2004 Oct; 10 Suppl 4():55-63. PubMed ID: 15479373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain.
    Batlle J; Villar A; Liras A; Alonso C; Altisent C; Brito D; Moreno M; Lucía F; Sedano C; Prieto M; Calvente N; Aznar JA; Jiménez V; Soriano V; Martorell JR; Iruín G; Bergua JM; Aguilar C
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):333-40. PubMed ID: 18600079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.